0.3174
price up icon2.62%   0.0081
pre-market  Pre-mercato:  .30   -0.0174   -5.48%
loading

Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
6.06%
16.88
15.92 16.12 17.86 21.25
Operating Income/Loss
6.06%
-16.88
-15.92 -16.12 -17.86 -21.25
Income/Loss From Continuing Operations Before Tax
7.83%
-16.64
-15.44 -15.55 -17.47 -20.13
Income/Loss From Continuing Operations After Tax
7.83%
-16.64
-15.44 -15.43 -18.18 -20.13
Net Income/Loss
7.83%
-16.64
-15.44 -15.43 -18.18 -20.13
Preferred Stock Dividends And Other Adjustments
-
- - - 0.234
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.43%
41.44
41.27 1.2428 41.21 39.12
Diluted Average Shares
0.43%
41.44
41.27 1.2428 41.21 39.12
Basic Earnings Per Share
8.11%
-0.40
-0.37 -0.37 -0.44 -0.52
Diluted Earnings Per Share
8.11%
-0.40
-0.37 -0.37 -0.44 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - 0.234
$35.42
price up icon 0.77%
$83.90
price up icon 0.91%
$28.24
price up icon 0.89%
$99.26
price up icon 1.41%
$144.75
price up icon 1.12%
biotechnology ONC
$327.20
price down icon 1.53%
Capitalizzazione:     |  Volume (24 ore):